Literature DB >> 8630595

Does oxygen help dyspnea in patients with cancer?

S Booth1, M J Kelly, N P Cox, L Adams, A Guz.   

Abstract

Dyspnea in patients with advanced cancer is a common symptom that is difficult to treat. This study investigated whether oxygen helps to relieve rest dyspnea in patients with advanced cancer. In a single-blind controlled trial, oxygen and air were administered in random order to hospice patients reporting dyspnea at rest. Measurements of arterial oxygen saturation, lung function, and dyspnea (using a visual analogue scale [VAS] and Borg score) were made before and after each gas had been given for 15 min. Data from 38 patients were used: analysis of variance revealed that mean VAS levels during baseline conditions, breathing room air (59 mm), were significantly reduced after administration of either air (48 mm; p < 0.001) or oxygen (45 mm; p < 0.001); there was no significant difference for the mean VAS scores between oxygen and air administration. There was no statistically significant order of treatment effect. There was no difference in the response to oxygen or air in patients with a history of cardiopulmonary disease. The improvement in dyspnea with oxygen could not be predicted from a subject's initial level of hypoxia. Results suggested that benzodiazepines may potentiate the effect of oxygen. The overall conclusion is that oxygen and air can have a significant effect in reducing dyspnea at rest in patients with advanced cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630595     DOI: 10.1164/ajrccm.153.5.8630595

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

Review 1.  WITHDRAWN: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Authors:  Claudia Bausewein; Sara Booth; Marjolein Gysels; Irene J Higginson
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

2.  Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial.

Authors:  Amy P Abernethy; Christine F McDonald; Peter A Frith; Katherine Clark; James E Herndon; Jennifer Marcello; Iven H Young; Janet Bull; Andrew Wilcock; Sara Booth; Jane L Wheeler; James A Tulsky; Alan J Crockett; David C Currow
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

Review 3.  Symptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literature.

Authors:  Matthäus Strieder; Martin Pecherstorfer; Gudrun Kreye
Journal:  Wien Med Wochenschr       Date:  2017-09-18

4.  Patients' experience of oxygen therapy and dyspnea: a qualitative study in home palliative care.

Authors:  Darin Jaturapatporn; Erica Moran; Chris Obwanga; Amna Husain
Journal:  Support Care Cancer       Date:  2010-03-21       Impact factor: 3.603

5.  Evaluation of diagnostic and treatment approaches towards acute dyspnea in a palliative care setting among medical students at the University of Vienna.

Authors:  Gudrun Pohl; Christine Marosi; Karin Dieckmann; Gregor Goldner; Katarzyna Elandt; Marco Hassler; Michael Schemper; Kathrin Strasser-Weippl; Friedemann Nauck; Jan Gaertner; Herbert Watzke
Journal:  Wien Med Wochenschr       Date:  2012-01

Review 6.  Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults.

Authors:  Shoab A Nazir; Marcia L Erbland
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 7.  An approach to dyspnea in advanced disease.

Authors:  Romayne Gallagher
Journal:  Can Fam Physician       Date:  2003-12       Impact factor: 3.275

8.  Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study.

Authors:  Katri Elina Clemens; Ines Quednau; Eberhard Klaschik
Journal:  Support Care Cancer       Date:  2008-08-22       Impact factor: 3.603

Review 9.  Oxygen or air for palliation of breathlessness in advanced cancer.

Authors:  Sara Booth; Rosemary Wade
Journal:  J R Soc Med       Date:  2003-05       Impact factor: 18.000

Review 10.  Palliative management of refractory dyspnea in COPD.

Authors:  Hope E Uronis; David C Currow; Amy P Abernethy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.